openPR Logo
Press release

Yaz, Yasmin to Get New Labels as FDA Warns of Blood Clot Risk

04-11-2012 08:33 AM CET | Politics, Law & Society

Press release from: Nadrich & Cohen LLP

Nadrich & Cohen, LLP reports that Yaz and similar birth control pills are to receive updated warning labels advising patients of the risk for developing serious blood clots.

Los Angeles, CA, April 10, 2012 – National law firm Nadrich & Cohen, LLP has learned that the U.S. Food and Drug Administration has ordered Bayer to produce new warning labels for several of its oral contraceptives, including Yaz, Yasmin and Beyaz. The new labels must make patients aware of the increased risk of blood clots associated with these and other birth control pills containing the synthetic hormone drospirenone.

The decision comes after an FDA advisory panel convened in December 2011 to discuss the future of Yaz after numerous research studies indicated that women who used the drug were at risk for developing serious complications, including deep vein thrombosis (DVT) and pulmonary embolism. While the panel ultimately voted 15-11 to allow the continued sale of Yaz, its members also recommended that Bayer update the drug’s warning labels.

Specifically, the FDA will require the new labels to inform consumers that research studies have indicated up to a threefold risk of developing blood clots in women who use contraceptives containing drospirenone versus those who use older types of birth control pills. FDA officials also advised women who to speak with their physician or other health care professional about the potential blood clot risk associated with any type of oral contraceptive before taking the drug.

Bayer is currently facing several thousand lawsuits filed in connection with blood clots and other complications caused by Yaz. Bellwether trials in the federal Yaz litigation were scheduled to begin in January but the presiding judge ordered both sides to mediation. Last month, the company announced that it settled approximately 70 of these claims and would consider additional settlements on a case-by-case basis. The bellwether trials are scheduled to resume at the end of April if mediation talks are unsuccessful.

Attorney Jeffrey Nadrich believes that more Yaz side effects lawsuits will continue to be filed if additional women are injured by the drug. Affected patients and their families may be eligible to file a claim for compensation. These individuals are encouraged to seek the aid of an experienced personal injury lawyer to discuss their legal rights.

Nadrich & Cohen LLP is offering confidential, no-cost consultations to women who experienced complications after using Yaz. Help is available by calling the firm’s injury hotline at 1-800-718-4658 or by completing an online contact form at www.yazbirthcontrolinjury.com.

Nadrich & Cohen LLP is a national law firm with offices in Los Angeles, Sacramento, San Diego and other cities throughout California specializing in handling mass tort actions and representing individuals in cases involving pharmaceutical companies and medical device manufacturers. The firm is committed to achieving the best outcome possible in every case and has recovered over $200 million in settlements on behalf of its clients.

In addition to handling Yaz side effects claims, the firm is also actively investigating cases involving Actos, DePuy ASR hips, vaginal mesh, Zoloft, Fosamax, Paxil, Wright Conserve Hips, Stevens-Johnson Syndrome, Benzene, Reflex Sympathy Dystrophy, Fen Phen and Asbestos exposure. For more information, visit www.personalinjurylawcal.com.

Contact:

Jennifer Poole
National Client Intake Coordinator
Nadrich & Cohen LLP
12100 Wilshire Blvd.
Suite 1250
Los Angeles, CA 90025
800-718-4658
info@personalinjurylawcal.com
www.personalinjurylawcal.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Yaz, Yasmin to Get New Labels as FDA Warns of Blood Clot Risk here

News-ID: 217538 • Views: 5254

More Releases from Nadrich & Cohen LLP

Yaz Lawsuit Settlements Reach $142 Million
Nadrich & Cohen, LLP reports that Bayer is continuing to offer settlements to plaintiffs involved in federal Yaz side effects litigation. Los Angeles, CA, April 27, 2012 – Nadrich & Cohen, LLP reports that German drug-maker Bayer AG has settled approximately 651 Yaz side effects lawsuits totaling $142 million. Earlier this month, it was reported that the drug-maker had reached settlements in approximately 500 cases filed by women who claimed
FDA Schedules Advisory Panel Meeting to Discuss Metal Hip Safety
Nadrich & Cohen, LLP reports that the FDA has scheduled an advisory panel to discuss the safety of metal hip implants. Los Angeles, CA, March 29, 2012 – National law firm Nadrich & Cohen, LLP has learned that the U.S. Food and Drug Administration has a scheduled an advisory panel meeting to discuss the safety of metal hip implants and all-metal hip resurfacing systems. The two-day panel, which is expected
Pradaxa Side Effects Lawsuits Filed in Federal Court
Nadrich & Cohen, LLP reports that three Pradaxa side effects lawsuits have been filed in federal courts across the country. Los Angeles, CA, March 7, 2012 – National law firm Nadrich & Cohen, LLP has learned that three Pradaxa side effects lawsuits have been filed against Boehringer Ingelheim, the drug’s manufacturer. The cases were filed in federal district courts located in Tennessee, Kentucky and Louisiana and it’s believed they are the
Bayer Agrees to Settlement in 70 Yaz Side Effects Lawsuits
Nadrich & Cohen, LLP reports that Bayer has agreed to settlements with a number of plaintiffs who sued the company over Yaz side effects. Los Angeles, CA, March 5, 2012 – National law firm Nadrich & Cohen, LLP reports that Bayer Healthcare has agreed to settle approximately 70 lawsuits filed on behalf of women who claim they were seriously injured by Yaz birth control pills. The amount of the settlements has

All 5 Releases


More Releases for Yaz

Global Automotive Aftermarket Industry Forecasts by Key Players: Bridgestone, De …
Market Overview:- Global Automotive aftermarket industry is led by replacement parts accounting for over USD 350 billion in 2015. These parts are used as replacement over original auto parts after wear & tear, damage or reduction in vehicle performance. Request For Sample Copy Of This Report @ https://www.gminsights.com/request-sample/detail/1166 Top Key Players:- The key players of global Automotive Aftermarket Industry are Bridgestone Corporation, Denso Corporation,
Global Yttria Alumina Zirconia (YAZ) Market 2016-2021: Industry Size, Share, Ana …
The 'Global and Chinese Yttria Alumina Zirconia (YAZ) Market, 2016-2021 Market Research Report' is a professional and in-depth study on the current state of the global Yttria Alumina Zirconia (YAZ) industry with a focus on the Chinese market. The report provides key statistics on the market status of the Yttria Alumina Zirconia (YAZ) manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the
A slice of the Orient in Stuttgart
Fraunhofer experts help get the YAZ restaurant concept off to a successful start in Stuttgart Food, glorious food. Not only must it taste good, but the service has to be right, too. And here’s a winning recipe: Before opening the doors of its flagship restaurant in Stuttgart in September 2013, the YAZ Company put a test version through its paces – in collaboration with service engineering experts from Fraunhofer IAO. YAZ is
Yaz Lawsuit Settlements Reach $142 Million
Nadrich & Cohen, LLP reports that Bayer is continuing to offer settlements to plaintiffs involved in federal Yaz side effects litigation. Los Angeles, CA, April 27, 2012 – Nadrich & Cohen, LLP reports that German drug-maker Bayer AG has settled approximately 651 Yaz side effects lawsuits totaling $142 million. Earlier this month, it was reported that the drug-maker had reached settlements in approximately 500 cases filed by women who claimed
Bayer Agrees to Settlement in 70 Yaz Side Effects Lawsuits
Nadrich & Cohen, LLP reports that Bayer has agreed to settlements with a number of plaintiffs who sued the company over Yaz side effects. Los Angeles, CA, March 5, 2012 – National law firm Nadrich & Cohen, LLP reports that Bayer Healthcare has agreed to settle approximately 70 lawsuits filed on behalf of women who claim they were seriously injured by Yaz birth control pills. The amount of the settlements has
Nadrich & Cohen LLP Clarifies Statements Regarding Actos Bladder Cancer Lawsuits
Los Angeles, CA, January 24, 2012 – National law firm Nadrich & Cohen LLP would like to clarify previous statements regarding the pending Actos bladder cancer litigation. Earlier press releases included incorrect information regarding the total number of Actos lawsuits filed against the drug’s manufacturer, Takeda Pharmaceuticals. Those releases, based on media reports, estimated the number of lawsuits filed in state and federal courts nationwide in connection with Actos numbered